Osiris sets up division for biotech devices

08/5/2009 | American City Business Journals

Osiris Therapeutics established a biosurgery unit that focuses on developing and commercializing biotech devices for orthopedic procedures. The division comprises doctors, scientists, and regulatory and manufacturing experts who developed Osteocel, a line of medical devices sold by Osiris to NuVasive for $85 million.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY